CardioVascular BioTherapeutics, Inc. — Form D

CardioVascular BioTherapeutics, Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-14. The offering totals $49.0M. Industry: Biotechnology.

Offering

• Filed: 2015-01-14
• Form: D
• Accession: 0001303497-15-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $49.0M
• Remaining: $49.0M
• Minimum investment: $1K
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-232247

Issuer

• Name: CardioVascular BioTherapeutics, Inc.
• CIK: 0001303497
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 9500 Hillwood Drive, Suite 200A, LAS VEGAS, NV, 89134
• Phone: 702-839-7200

Officers, directors & promoters (8)

More

• CIK 1303497 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search